# OnCo record paper-topham-subtype-discordant-pancreatic-ccr-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-topham-subtype-discordant-pancreatic-ccr-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-topham-subtype-discordant-pancreatic-ccr-2021" ;
  schema:name "Subtype-discordant pancreatic ductal adenocarcinoma tumors show intermediate clinical and molecular characteristics"@en ;
  schema:description "Running six published subtype classifiers over 574 tumours, the authors found they agreed in 88% of cases, and the 12% they disagreed on were genuine hybrids with intermediate survival and intermediate KRAS allele imbalance."@en ;
  schema:url <https://onco.cc/key-papers/paper-topham-subtype-discordant-pancreatic-ccr-2021/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1078-0432.CCR-20-2831>, <https://pubmed.ncbi.nlm.nih.gov/33051307/> ;
  schema:sameAs <https://doi.org/10.1158/1078-0432.CCR-20-2831> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Topham JT, Karasinska JM, Lee MKC, et al." ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:technologies <https://onco.cc/technologies/rna-seq/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:institutions <https://onco.cc/institutions/bc-cancer/> ;
  onco:journals <https://onco.cc/journals/clinical-cancer-research/> .